Status:
RECRUITING
E-intervention on Subclinical Fear of Cancer Recurrence
Lead Sponsor:
The University of Hong Kong
Collaborating Sponsors:
Health and Medical Research Fund
Conditions:
Cancer
Psychooncology
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The present study aims to adapt a metacognition-based ConquerFear-HK to an internet-based self-management intervention, namely eConquerFear-HK and evaluate in a randomised controlled trial, its feasib...
Detailed Description
A pilot randomised controlled feasibility trial will used to test the feasibility, utility, and potential effectiveness of an internet-based self-management intervention for fear of cancer recurrence ...
Eligibility Criteria
Inclusion
- Cantonese- or Mandarin-speaking Chinese cancer survivors
- recently diagnosed with potentially curable (stage 0 to III) colorectal or breast cancer
- had recently completed surgery as primary treatment
- have completed hospital-based adjuvant treatments (including radiotherapy and chemotherapy) within the past six months
- scored 13 to 21 on the fear of cancer recurrence-short form will be recruited.
Exclusion
- non-Chinese ethnicity
- metastatic cancer
- with current diagnosis of depression or psychosis or are currently receiving psychological treatments
- language or intellectual difficulties that prevent them from understanding the intervention content
- having limited or no Internet access.
Key Trial Info
Start Date :
May 2 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2025
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT06207006
Start Date
May 2 2024
End Date
December 30 2025
Last Update
October 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Queen Mary Hospital-Department of Surgery
Hong Kong, Hong Kong